Protherics PLC
6 monthly Block Listing Return
Approved Executive Share Option Scheme
London, UK; Brentwood, TN, US: 10 April 2007 - Protherics PLC ("Protherics" or
the "Company"), the international biopharmaceutical company focused on critical
care and cancer, announces that the following 6 monthly block listing return in
respect of the Company's Approved Executive Share Option Scheme has been lodged
with the FSA today, in accordance with Listing Rule 3.5.6.
Name of applicant: Protherics PLC
Name of scheme: Protherics PLC Approved Executive Share Option Scheme
Period of return: From: 9 October 2006 To: 8 April 2007
Balance under scheme from previous return: 356,924
The amount by which the block scheme has been increased, Nil
if the scheme has been increased since the date of the
last return:
Number of securities issued/allotted under scheme during 21,625
period:
Balance under scheme not yet issued/allotted at end of 335,299
period
Number and class of securities originally listed and the 387,712 Ordinary Shares (date of admission: 8 April 2005)
date of admission
Total number of securities in issue at the end of the 339,169,625
period
| Ends |
For further information please contact:
Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary +44 (0)1928 518000
Financial Dynamics - press enquiries
London: Ben Atwell, Anna Keeble +44 (0) 20 7831 3113
New York: John Capodanno, Jonathan Birt +1 212 850 5600
Or visit www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange
Protherics PLC announces Blocklisting Interim Review
| Source: Protherics PLC
Cheshire, UK -- (MARKET WIRE) -- April 10, 2007 --